Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
20.11.2024 15:06:06
|
Insulet Says Omnipod 5 AID System Now Compatible With Abbott's FreeStyle Libre 2 Plus CGM Sensor
(RTTNews) - Insulet Corp. (PODD), a provider of tubeless insulin pump technology, announced Wednesday that the Omnipod 5 Automated Insulin Delivery (AID) System is now compatible with Abbott Laboratories' (ABT) FreeStyle Libre 2 Plus continuous glucose monitoring (CGM) sensor in the U.S.
This makes Omnipod 5 the most connected tubeless AID system in the U.S. As the number one prescribed and number one favorite pump in the U.S., the waterproof, discreet, and wearable Omnipod 5 is the first tubeless AID system that communicates with a CGM, proactively correcting for highs and helping to protect against lows, day and night.
The Omnipod 5 System simplifies diabetes management and has shown to improve results by eliminating the need for multiple daily injections (MDI) therapy and automatically adjusting insulin delivery every five minutes using its advanced SmartAdjust technology.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratoriesmehr Nachrichten
18.07.25 |
Minuszeichen in New York: So entwickelt sich der S&P 500 am Freitagnachmittag (finanzen.at) | |
18.07.25 |
NASDAQ-Handel: NASDAQ Composite legt zum Start des Freitagshandels zu (finanzen.at) | |
17.07.25 |
Börse New York: NASDAQ Composite beendet den Handel im Plus (finanzen.at) | |
17.07.25 |
Zuversicht in New York: S&P 500 zeigt sich letztendlich fester (finanzen.at) | |
17.07.25 |
Gewinne in New York: NASDAQ Composite legt zu (finanzen.at) | |
17.07.25 |
S&P 500 aktuell: Am Nachmittag Pluszeichen im S&P 500 (finanzen.at) | |
17.07.25 |
Aufschläge in New York: S&P 500 am Donnerstagmittag fester (finanzen.at) | |
17.07.25 |
Gute Stimmung in New York: NASDAQ Composite verbucht mittags Zuschläge (finanzen.at) |
Analysen zu Abbott Laboratoriesmehr Analysen
Aktien in diesem Artikel
Abbott Laboratories | 107,04 | 0,36% |
|
Insulet Corp Shs | 241,40 | 0,17% |
|